azomycin has been researched along with amoxicillin in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.57) | 18.7374 |
| 1990's | 7 (25.00) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 7 (25.00) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Ainley, C; Altare, F; Ansaldi, N; Holton, J; Oderda, G; Vaira, D | 1 |
| Hackelsberger, A; Malfertheiner, P | 1 |
| Johnston, BJ; Reed, PI | 1 |
| Misiewicz, JJ | 1 |
| Bell, JM; Grayson, ML; Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Scheen, AJ | 1 |
| Mégraud, F | 1 |
| Gisbert, JP | 1 |
| De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL | 1 |
| Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M | 1 |
| Calvet, X; Gabriel, R; García, N; Gisbert, JP; González, L; López, T; Pajares, JM; Roqué, M | 1 |
| De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL | 1 |
| Kuipers, EJ; Kusters, JG | 1 |
| Börsch, G; Kahl, S; Labenz, J; Leodolter, A; Malfertheiner, P; Peitz, U; Stolte, M; Sulliga, M; Von Arnim, U; Wolle, K | 1 |
| Malfertheiner, P; Pilotto, A | 1 |
| Hall, K; Meredith, S; Murray, KT; Narasimhulu, SS; Ray, WA; Stein, CM | 1 |
| Calvet, X; Gisbert, JP; Gonzalez, L | 1 |
| Moayyedi, P | 1 |
| Essa, AS; Graham, DY; Kramer, JR; Treiber, G | 1 |
| Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S; Vilaichone, RK | 1 |
| Calvet, X; Gisbert, JP | 1 |
| Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y | 1 |
| Kang, BK; Kim, BW; Park, SM | 1 |
| Almeida, N; Calhau, C; Cardoso, O; Cipriano, MA; Donato, MM; Fernandes, A; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Guo, B; Li, BZ; Li, P; Mao, C; Threapleton, DE; Wang, JY; Xu, JM; Ye, DQ; Ye, QL; Yuan, JQ; Zhang, C | 1 |
| Atherton, J; Axon, AT; Bazzoli, F; El-Omar, EM; Gasbarrini, A; Gisbert, JP; Graham, DY; Hunt, R; Kuipers, EJ; Malfertheiner, P; Megraud, F; Moayyedi, P; O'Morain, CA; Rokkas, T; Rugge, M; Selgrad, M; Suerbaum, S; Sugano, K | 1 |
| Birkenfeld, S; Boltin, D; Dotan, I; Gabay, H; Gingold-Belfer, R; Levi, Z; Schmilovitz-Weiss, H; Shochat, T | 1 |
| Chen, J; Ding, Z; Huang, Y; Liang, X; Lu, H | 1 |
17 review(s) available for azomycin and amoxicillin
| Article | Year |
|---|---|
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines | 1996 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 1997 |
Management of Helicobacter pylori-related disorders.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pumps | 1997 |
Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Helicobacter pylori; Humans; Macrolides; Nitroimidazoles; Penicillin Resistance | 1998 |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Nitroimidazoles; Omeprazole; Penicillins | 1999 |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2000 |
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 2000 |
Antibiotic resistance of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline | 2001 |
Review article: an approach to Helicobacter pylori infection in the elderly.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Peptic Ulcer; Treatment Failure | 2002 |
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 2005 |
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2009 |
Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2011 |
Optimum duration of regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones | 2013 |
[New therapeutic strategies against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors | 2014 |
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Nitroimidazoles; Probiotics; Proton Pump Inhibitors | 2015 |
Susceptibility testing alone will not reliably achieve high Helicobacter pylori cure rates: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2022 |
3 trial(s) available for azomycin and amoxicillin
| Article | Year |
|---|---|
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors | 2000 |
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Treatment Outcome | 2002 |
Sequential regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2007 |
9 other study(ies) available for azomycin and amoxicillin
| Article | Year |
|---|---|
Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels.
Topics: Administration, Oral; Adolescent; Amoxicillin; Antibodies, Bacterial; Campylobacter; Campylobacter Infections; Child; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrins; Gastritis; Humans; Immunoglobulin G; Male; Nitroimidazoles; Pepsinogens; Pyloric Antrum; Recurrence; Tinidazole | 1989 |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; Nitroimidazoles; Tetracycline | 1997 |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer | 1998 |
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome | 2001 |
Oral erythromycin and the risk of sudden death from cardiac causes.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Calcium Channel Blockers; Confounding Factors, Epidemiologic; Cytochrome P-450 CYP3A; Death, Sudden, Cardiac; Diltiazem; Drug Interactions; Erythromycin; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nitroimidazoles; Oxidoreductases, N-Demethylating; Risk; Troleandomycin; Verapamil | 2004 |
Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Chi-Square Distribution; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Nitroimidazoles; Odds Ratio; Point Mutation; Polymerase Chain Reaction; Predictive Value of Tests; Proton Pump Inhibitors; Ribotyping; Risk Assessment; Risk Factors; RNA, Ribosomal, 23S; Thailand; Time Factors; Treatment Outcome | 2011 |
Beyond Maastricht IV: are standard empiric triple therapies for Helicobacter pylori still useful in a South-European country?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Nitroimidazoles; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Young Adult | 2015 |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Early Detection of Cancer; Evidence-Based Medicine; Fluoroquinolones; Gastritis; Gastrointestinal Microbiome; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Practice Guidelines as Topic; Proton Pump Inhibitors; Risk Factors; Stomach; Stomach Neoplasms | 2017 |
Effect of Previous Nitroimidazole Treatment on Helicobacter pylori Eradication Success.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Proton Pump Inhibitors; Treatment Outcome | 2020 |